3rd International Conference on Plant Synthetic Biology, Bioengineering, and Biotechnology
Using Synthetic Biology to Produce High-Value Diterpenoids in Chlamydomonas Reinhardtii
Authors
We have exploited the green microalga, Chlamydomonas reinhardtii, as a chassis organism for scalable and high-throughput production of medicinal compounds. We are taking a synthetic biology driven approach, following the principle of design, build, and test to overcome the scalability constraints associated with first-generation engineered algal platforms. Using functionally defined standardised parts and workflows, we are able to predictably generate C. reinhardtii strains that efficiently express multiple heterologous genes. For control of transgene expression, we have developed a versatile and easily regulated system based on thiamine-pyrophosphate riboswitches, which are responsive to the concentration of thiamine and its analogues in the growth medium. Using these strategies and molecular resources we are engineering C. reinhardtii for scalable production of diterpenoids with medicinal properties.
Scranton, M. A. et al. Algal Research 15, 135â142 (2016)
Scaife, M. A. et al. The Plant Journal 82, 532â546 (2015)
Nguyen, G. T. et al. J. Phycology. 52, 320â328 (2016).
Keyword
Synthetic biology, metabolic engineering, microalgae, riboswitch, diterpenoids